Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

Clinical trial NCT04884035 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04884035
Sponsor: Celgene
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2021-09-15
Primary completion: 2028-12-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.